ClinicalTrials.gg
CompletedNCT03298841Updated Apr 22, 2021Results posted

Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope

An observational study in Cataract, sponsored by Toyos Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-22.

Sponsored by Toyos Clinic · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Study design will be a mix of retrospective (older Zeiss microscope previously in use at our surgery center) and prospective data collection with the Lumera and Callisto software.

The Lumera and Callisto software system will be used for all cataract surgeries including toric analyses and lens placement.

Read the detailed description

Needs Assessment

Research on this topic is needed as over 3 million cataract surgeries are performed in the United States each year. The number of surgeries performed is growing as baby boomers age. Reimbursements continue to decline, necessitating ever improving operating and surgical efficiencies in the operating room setting for physicians and small business owners to remain financially viable. New governmental regulations dictate that physician payments will be related to patient satisfaction and outcomes which may be better provided by newer and better surgical technologies.

The Lumera operating microscope and Callisto software system provide several features that may enhance operating room flow including HD video screen and co-observant microscopes that can be independently adjusted to help operating room staff anticipate the needs of the surgeon. Enhanced retroillumination would be expected to translate into fewer complications and more confidence during surgery which could lead to less operating time, phaco energy used and improved visual outcomes. The toric alignment assistance device may lead to more accurate toric placement and improved visual outcomes after surgery.

Target audience would include all cataract surgeons both high and lower volume.

There is currently a dearth of published literature on this technology and its benefits in routine cataract surgery. There are no registered similar trials on Clinicaltrials.gov

02

Conditions studied

  • Cataract

Browse trials for

03

In context

Cataract

1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.

This study's enrollment of 50 is below the median of 89 across 475 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Toyos Clinic is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

100 patients with visually significant cataracts

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Visually significant cataract

Exclusion criteria

Exclusion Criteria:

  • Not visually significant cataract
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50 participants (actual)
Patient registry
No

Interventions

  • DeviceZeiss

    This study proposal will highlight the advanced technology features of the Zeiss Lumera surgical operating microscope which include but are not limited to: Stereo Coaxial Illumination for improved visualization High resolution video screen/co-observation tool to help OR staff anticipate next steps Integrated toric alignment tool Surgical microscope touch screen Cordless foot control for faster turnover between cases

06

What researchers measure

Primary outcomes

  1. Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope

    operating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center

    Time frame: during surgery assessed up to one hour

Secondary outcomes

  1. Number of Serious Adverse Events During Intra-operative and Post-operative Period

    events that are life or vision threatening, that require hospitalization or permanent disability of any type

    Time frame: 6 weeks

07

Results

Posted Apr 22, 2021

Participant flow

Participant flow — Overall Study
MilestoneZeiss GroupLeica Stativ S3B
Started2525
Completed2525
Not completed00

Outcome measures

PrimaryImprovement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope

operating times during cataract surgery will be measured with the use of the new Lumera operating microscope versus an older Zeiss model operating scope by two experienced cataract surgeons in a single surgery center

Time frame:
during surgery assessed up to one hour
Reported as:
Mean · minutes per surgical procedure
Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope
minutes per surgical procedureZeiss GroupLeica Stativ S3B
Improvement in Operating Room Efficiencies During Cataract Surgery With the Use of the New Lumera Operating Microscope Versus an Older Zeiss Model Operating Scope11.15 ± 2.4214.18 ± 8.67
SecondaryNumber of Serious Adverse Events During Intra-operative and Post-operative Period

events that are life or vision threatening, that require hospitalization or permanent disability of any type

Time frame:
6 weeks
Reported as:
Count of participants · Participants
Number of Serious Adverse Events During Intra-operative and Post-operative Period
ParticipantsCataract Surgery Patients
Number of Serious Adverse Events During Intra-operative and Post-operative Period0

Adverse events

Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Zeiss Group0/25 (0%)0/25 (0%)0/25 (0%)
Leica Stativ S3B0/25 (0%)0/25 (0%)0/25 (0%)

Baseline characteristics

sequential series of patients with uncomplicated cataracts undergoing phacoemulsification at one surgery site

Age, Categorical
Age, Categorical(Participants)Zeiss GroupLeica Stativ S3BTotal
<=18 years000
Between 18 and 65 years222345
>=65 years325
Sex: Female, Male
Sex: Female, Male(Participants)Zeiss GroupLeica Stativ S3BTotal
Female151631
Male10919
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Zeiss GroupLeica Stativ S3BTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Zeiss GroupLeica Stativ S3BTotal
United States252550
08

Study locations

1 site
  • Toyos Clinic
    Nashville, Tennessee 37203, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03298841
Lead sponsor
Toyos Clinic
Responsible party
Melissa Toyos (Principal Investigator, Toyos Clinic) — Principal investigator
First posted
Oct 2, 2017
Start date
Mar 1, 2017
Primary completion
Sep 20, 2017
Completion
Sep 20, 2017
Results posted
Apr 22, 2021
Last update
Apr 22, 2021

Study contacts

Melissa Toyos, md
principal investigator · Toyos Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion